Differential inhibition of human cytomegalovirus (HCMV) by toll-like receptor ligands mediated by interferon-beta in human foreskin fibroblasts and cervical tissue

Virology Journal

Volumn 4, Issue , 2007, Pages

  Harwani, Sailesh C ^a   Lurain, Nell S ^a   Zariffard, M Reza ^a   Spear, Gregory T ^a  

^a RUSH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETA INTERFERON; BETA INTERFERON ANTIBODY; CPG 2395; CPG OLIGODEOXYNUCLEOTIDE; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; LIGAND; TOLL LIKE RECEPTOR;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; EMBRYO; FEMALE; FIBROBLAST; GENITAL SYSTEM; GENITAL TRACT INFECTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; IN VIVO STUDY; MALE; MICROFLORA; MODEL; PREPUCE; PROTEIN SECRETION; UTERINE CERVIX; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS SHEDDING; BIOSYNTHESIS; CELL CULTURE; CYTOMEGALOVIRUS; IMMUNOLOGY; METABOLISM; SECRETION; VIROLOGY;

HUMAN HERPESVIRUS 5;

CELLS, CULTURED; CERVIX UTERI; CYTOMEGALOVIRUS; FEMALE; FIBROBLASTS; FORESKIN; HUMANS; INTERFERON-BETA; INTERLEUKIN-8; LIGANDS; LIPOPOLYSACCHARIDES; MALE; POLY I-C; TOLL-LIKE RECEPTORS; VIRUS SHEDDING;

EID: 38849196295     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-4-133     Document Type: Article

References (41)

1. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. SA Staras SC Dollard KW Radford WD Flanders RF Pass MJ Cannon, Clin Infect Dis 2006 43 9 1143 1151 10.1086/508173 17029132
2. Infection in organ-transplant recipients. JA Fishman RH Rubin, N Engl J Med 1998 338 24 1741 1751 10.1056/NEJM199806113382407 9624195
3. Cytomegalovirus infection in sex partners: evidence for sexual transmission. HH Handsfield SH Chandler VA Caine JD Meyers L Corey E Medeiros JK McDougall, J Infect Dis 1985 151 2 344 348 2981937
4. Association between genital tract cytomegalovirus infection and bacterial vaginosis. SA Ross Z Novak G Ashrith LB Rivera WJ Britt S Hedges JR Schwebke AS Boppana, J Infect Dis 2005 192 10 1727 1730 10.1086/497150 16235170
5. Vaginitis. JD Sobel, N Engl J Med 1997 337 26 1896 1903 10.1056/NEJM199712253372607 9407158
6. Factors associated with cytomegalovirus infection among human immunodeficiency virus type 1-seronegative and -seropositive women from an urban minority community. LM Clarke A Duerr J Feldman MF Sierra BJ Daidone SH Landesman, J Infect Dis 1996 173 1 77 82 8537686
7. Sexually transmitted diseases in mothers of neonates with congenital cytomegalovirus infection. KB Fowler RF Pass, J Infect Dis 1991 164 2 259 264 1649872
8. The Lip lipoprotein from Neisseria gonorrhoeae stimulates cytokine release and NF-kappaB activation in epithelial cells in a Toll-like receptor 2-dependent manner. PL Fisette S Ram JM Andersen W Guo RR Ingalls, The Journal of biological chemistry 2003 278 47 46252 46260 10.1074/jbc.M306587200 12966099
9. Trichomonas vaginalis infection activates cells through toll-like receptor 4. MR Zariffard S Harwani RM Novak PJ Graham X Ji GT Spear, Clin Immunol 2004 111 1 103 107 10.1016/j.clim.2003.12.008 15093558
10. TLR2-mediated cell stimulation in bacterial vaginosis. D Mares JA Simoes RM Novak GT Spear, J Reprod Immunol 2007 17532476
11. Innate immune recognition of nucleic acids: beyond toll-like receptors. KJ Ishii S Akira, Int J Cancer 2005 117 4 517 523 10.1002/ijc.21402 16080197
12. Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. AA Ashkar S Bauer WJ Mitchell J Vieira KL Rosenthal, J Virol 2003 77 16 8948 8956 12885911 10.1128/JVI.77.16.8948-8956.2003
13. Induction of antiviral immunity requires Toll-like receptor signaling in both stromal and dendritic cell compartments. A Sato A Iwasaki, Proc Natl Acad Sci U S A 2004 101 46 16274 16279 15534227 10.1073/pnas.0406268101
14. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. M Isogawa MD Robek Y Furuichi FV Chisari, J Virol 2005 79 11 7269 7272 15890966 10.1128/JVI.79.11.7269-7272.2005
15. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production. N Gill PM Deacon B Lichty KL Mossman AA Ashkar, J Virol 2006 80 20 9943 9950 17005672 10.1128/JVI.01036-06
16. The human cytomegalovirus major immediate-early enhancer determines the efficiency of immediate-early gene transcription and viral replication in permissive cells at low multiplicity of infection. H Isomura MF Stinski, J Virol 2003 77 6 3602 3614 12610136 10.1128/JVI.77.6.3602-3614.2003
17. Comparison of molecular tests for detection and quantification of cell-associated cytomegalovirus DNA. AM Caliendo B Yen-Lieberman J Baptista J Andersen C Crumpacker R Schuurman SA Spector J Bremer NS Lurain, Journal of clinical microbiology 2003 41 8 3509 3513 12904347 10.1128/JCM.41.8.3509-3513. 2003
18. Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue. AM Fox-Canale TJ Hope J Martinson JR Lurain AW Rademaker JW Bremer A Landay GT Spear NS Lurain, Virology 2007 17716703
19. Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates. NS Lurain KS Kapell DD Huang JA Short J Paintsil E Winkfield CA Benedict CF Ware JW Bremer, J Virol 1999 73 12 10040 10050 10559318
20. Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. Q Hu I Frank V Williams JJ Santos P Watts GE Griffin JP Moore M Pope RJ Shattock, J Exp Med 2004 199 8 1065 1075 10.1084/jem.20022212 15078900
21. Essential involvement of interleukin-8 (IL-8) in acute inflammation. A Harada N Sekido T Akahoshi T Wada N Mukaida K Matsushima, J Leukoc Biol 1994 56 5 559 564 7964163
22. Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts. DC Helfgott LT May Z Sthoeger I Tamm PB Sehgal, J Exp Med 1987 166 5 1300 1309 10.1084/jem.166.5.1300 2824651
23. Simultaneous production of interleukin 6, interferon-beta and colony-stimulating activity by fibroblasts after viral and bacterial infection. J Van Damme MR Schaafsma WE Fibbe JH Falkenburg G Opdenakker A Billiau, European journal of immunology 1989 19 1 163 168 10.1002/eji.1830190126 2646135
24. Induction of tumor necrosis factor- alpha secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis. MR Zariffard RM Novak N Lurain BE Sha P Graham GT Spear, J Infect Dis 2005 191 11 1913 1921 10.1086/429922 15871126
25. Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma. B Sainz Jr. HL LaMarca RF Garry CA Morris, Virol J 2005 2 14 15727684 10.1186/1743-422X-2-14
26. Mitogenic effect of double-stranded RNA in human fibroblasts: role of autogenous interferon. J Vilcek M Kohase D Henriksen-DeStefano, J Cell Physiol 1987 130 1 37 43 10.1002/jcp.1041300107 3805129
27. Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA. MJ Servant N Grandvaux BR tenOever D Duguay R Lin J Hiscott, The Journal of biological chemistry 2003 278 11 9441 9447 10.1074/jbc.M209851200 12524442
28. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. M Matsumoto S Kikkawa M Kohase K Miyake T Seya, Biochem Biophys Res Commun 2002 293 5 1364 1369 10.1016/S0006-291X(02)00380-7 12054664
29. Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. E Szomolanyi-Tsuda X Liang RM Welsh EA Kurt-Jones RW Finberg, J Virol 2006 80 9 4286 4291 16611887 10.1128/JVI.80.9.4286-4291.2006
30. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. T Compton EA Kurt-Jones KW Boehme J Belko E Latz DT Golenbock RW Finberg, J Virol 2003 77 8 4588 4596 12663765 10.1128/JVI.77.8. 4588-4596.2003
31. Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. KW Boehme M Guerrero T Compton, J Immunol 2006 177 10 7094 7102 17082626
32. Human NK cells inhibit cytomegalovirus replication through a noncytolytic mechanism involving lymphotoxin-dependent induction of IFN-beta. AC Iversen PS Norris CF Ware CA Benedict, J Immunol 2005 175 11 7568 7574 16301666
33. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. NM Lauzon F Mian R Mackenzie AA Ashkar, Cell Immunol 2006 17049504
34. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. A Krug AR French W Barchet JA Fischer A Dzionek JT Pingel MM Orihuela S Akira WM Yokoyama M Colonna, Immunity 2004 21 1 107 119 10.1016/j.immuni.2004.06.007 15345224
35. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. K Tabeta P Georgel E Janssen X Du K Hoebe K Crozat S Mudd L Shamel S Sovath J Goode L Alexopoulou RA Flavell B Beutler, Proc Natl Acad Sci U S A 2004 101 10 3516 3521 14993594 10.1073/pnas.0400525101
36. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. S Doyle S Vaidya R O'Connell H Dadgostar P Dempsey T Wu G Rao R Sun M Haberland R Modlin G Cheng, Immunity 2002 17 3 251 263 10.1016/S1074-7613(02)00390-4 12354379
37. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. V Toshchakov BW Jones PY Perera K Thomas MJ Cody S Zhang BR Williams J Major TA Hamilton MJ Fenton SN Vogel, Nat Immunol 2002 3 4 392 398 10.1038/ni774 11896392
38. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. HS Youn JY Lee KA Fitzgerald HA Young S Akira DH Hwang, J Immunol 2005 175 5 3339 3346 16116226
39. Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. RN Fichorova AO Cronin E Lien DJ Anderson RR Ingalls, J Immunol 2002 168 5 2424 2432 11859134
40. Triggering TLR signaling in vaccination. D van Duin R Medzhitov AC Shaw, Trends Immunol 2006 27 1 49 55 10.1016/j.it.2005.11.005 16310411
41. Transcriptional regulation of the human TRIF (TIR domain-containing adaptor protein inducing interferon beta) gene. MP Hardy GGAF Mc LA O'Neill, Biochem J 2004 380 Pt 1 83 93 14960149 10.1042/BJ20040030